Skip to content

Clinical trials

Completed Multiple Myeloma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: South Korea Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20063
20071
20082
20094
20102
20112
20128
20133
20147
20153
20164
20176
20183
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC7
Amgen5
Asan Medical Center4
Takeda4
Celgene3
GlaxoSmithKline3
Cooperative Study Group A for Hematology2
Janssen Korea, Ltd., Korea2
Millennium Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma55
Lymphoma7
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myeloid, Acute6
Neoplasms6
Recurrence6
Lymphoma, Non-Hodgkin5
Hodgkin Disease4
Lymphoma, Large B-Cell, Diffuse4
Myelodysplastic Syndromes4

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.